Document Detail

Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.
MedLine Citation:
PMID:  16236929     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Intracoronary calcium-channel blockers administered in the event of no reflow during percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) have been shown to improve myocardial perfusion. STUDY OBJECTIVE: To evaluate the effects of the administration of intracoronary verapamil before the occurrence of no reflow during direct PCI. DESIGN AND SETTING: Single-center, nonrandomized, prospective study with a retrospective control group. PATIENTS AND METHODS: From September 2001 to December 2003, 50 consecutive patients with AMI were prospectively enrolled for intracoronary verapamil treatment. Intracoronary verapamil was administered immediately prior to balloon inflation and at short intervals during the procedure thereafter. Retrospectively, 50 consecutive AMI patients who had undergone direct PCI and had not received intracoronary calcium-channel blockers were enrolled as control subjects. Patients with cardiogenic shock or platelet glycoprotein IIb/IIIa inhibitor were excluded. Thrombolysis in Myocardial Infarction (TIMI) flow grade, corrected TIMI frame count (CTFC), and TIMI myocardial perfusion grade (TMPG) were assessed prior to and following PCI by two independent cardiologists blinded to the procedures. RESULTS: The two groups had similar baseline and post-procedural angiographic characteristics, although the patients who been administered verapamil received more stent implantations than the control subjects (84% vs 60%, p = 0.008). Post-procedural TIMI flow < 3 (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.12 to 1.30; p = 0.18) and TMPG (OR, 1.24; 95% CI, 0.46 to 3.34; p = 0.68) were not associated with the implantation of the stents. There were no significant difference in post-PCI TIMI flow (p = 0.68) and CTFC (p = 0.36) between patients treated with verapamil and the control subjects. Post-PCI TMPG was significantly better in patients treated with intracoronary verapamil (p = 0.003). Forty-two percent of the patients treated with verapamil were found to have TMPG-3, while only 14% of the control subjects were found to have the same degree of TMPG (p = 0.004). Treatment with intracoronary verapamil (OR, 0.26; 95% CI, 0.12 to 0.58; p = 0.001) and pre-PCI TIMI flow (OR, 0.54; 95% CI, 0.35 to 0.84; p = 0.006) were found by multiple logistic regression to be independent predictors of TMPG. CONCLUSIONS: Early administration of intracoronary verapamil during direct PCI improves post-procedural myocardial perfusion, as evaluated by TMPG.
Chi-Ling Hang; Cha-Ping Wang; Hon-Kan Yip; Cheng-Hsu Yang; G Bih-Fang Guo; Chiung-Jen Wu; Shyh-Ming Chen
Related Documents :
23653269 - Relationship between impaired cardiac sympathetic activity and spatial dyssynchrony in ...
23804909 - Apical left ventriculotomy is safe in infants and young children requiring cardiac surg...
23924889 - Strain rate dispersion index can predict changes in left ventricular volume and adverse...
24808789 - A case of survival after cardiac arrest and 3½ hours of resuscitation.
24215199 - Creating the bioartificial myocardium for cardiac repair: challenges and clinical targets.
23935889 - Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and fu...
2588249 - Will emergency coronary bypass grafting after failed elective percutaneous transluminal...
21478129 - Visualization of coronary plaque rupture using optical coherence tomography.
127599 - Localized left ventricular myocardial defect leading to fatal cerebral embolism.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Chest     Volume:  128     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-20     Completed Date:  2005-11-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2593-8     Citation Subset:  AIM; IM    
Section of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, 123 Ta-Pei Rd, Niao-Sung Hsiang, Kaohsiung Hsien 833, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Balloon Dilatation
Blood Flow Velocity
Calcium Channel Blockers / administration & dosage,  therapeutic use
Coronary Angiography
Coronary Vessels
Injections, Intra-Arterial
Middle Aged
Myocardial Infarction / radiography,  therapy*
Retrospective Studies
Treatment Outcome
Verapamil / administration & dosage,  therapeutic use*
Reg. No./Substance:
0/Calcium Channel Blockers; 52-53-9/Verapamil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Seasonal diagnosis of echocardiographically demonstrated endocarditis.
Next Document:  Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension.